Feedback / Questions
NVI-100 - Nuvie Bio
https://www.businesswire.com/news/home/20250108581271/en/Emerging-Clinical-Stage-Neuroscience-Company-Nuvie-Bio-Announces-Positive-Phase-1-Data-with-its-Lead-Migraine-Program
Jan 8, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious